1. LooY-M, GaleMJr (2011) Immune signaling by RIG-I-like receptors. Immunity 34: 680–692.
2. YoneyamaM, KikuchiM, NatsukawaT, ShinobuN, ImaizumiT, et al. (2004) The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5: 730–737.
3. KatoH, TakahasiK, FujitaT (2011) RIG-I-like receptors: cytoplasmic sensors for non-self RNA. Immunol Rev 243: 91–98.
4. KatoH, TakeuchiO, SatoS, YoneyamaM, YamamotoM, et al. (2006) Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441: 101–105.
5. LooY-M, FornekJ, CrochetN, BajwaG, PerwitasariO, et al. (2008) Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol 82: 335–345.
6. PlumetS, HerschkeF, BourhisJ-M, ValentinH, LonghiS, et al. (2007) Cytosolic 5′-triphosphate ended viral leader transcript of measles virus as activator of the RIG I-mediated interferon response. PLoS One 2: e279.
7. SaitoT, HiraiR, LooY-M, OwenD, JohnsonCL, et al. (2007) Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc Natl Acad Sci USA 104: 582–587.
8. SatohT, KatoH, KumagaiY, YoneyamaM, SatoS, et al. (2010) LGP2 is a positive regulator of RIG-I–and MDA5-mediated antiviral responses. Proc Natl Acad Sci USA 107: 1512–1517.
9. WilkinsC, GaleM (2010) Recognition of viruses by cytoplasmic sensors. Curr Opin Immunol 22: 41–47.
10. FaulEJ, WanjallaCN, SutharMS, GaleMJr, WirblichC, et al. (2010) Rabies virus infection induces type I interferon production in an IPS-1 dependent manner while dendritic cell activation relies on IFNAR signaling. PLoS Path 6: e1001016.
11. IkegameS, TakedaM, OhnoS, NakatsuY, NakanishiY, et al. (2010) Both RIG-I and MDA5 RNA helicases contribute to the induction of alpha/beta interferon in measles virus-infected human cells. J Virol 84: 372–379.
12. SaitoT, GaleMJr (2007) Principles of intracellular viral recognition. Curr Opin Immunol 19: 17–23.
13. YountJS, GitlinL, MoranTM, LópezCB (2008) MDA5 participates in the detection of paramyxovirus infection and is essential for the early activation of dendritic cells in response to Sendai virus defective interfering particles. J Immunol 180: 4910–4918.
14. FujitaT, OnoguchiK, OnomotoK, HiraiR, YoneyamaM (2007) Triggering antiviral response by RIG-I-related RNA helicases. Biochimie 89: 754–760.
15. WangY, LudwigJ, SchuberthC, GoldeckM, SchleeM, et al. (2010) Structural and functional insights into 5′-ppp RNA pattern recognition by the innate immune receptor RIG-I. Nat Struct Mol Biol 17: 781–787.
16. CivrilF, BennettM, MoldtM, DeimlingT, WitteG, et al. (2011) The RIG-I ATPase domain structure reveals insights into ATP-dependent antiviral signalling. EMBO reports 12: 1127–1134.
17. JiangF, RamanathanA, MillerMT, TangG-Q, GaleM, et al. (2011) Structural basis of RNA recognition and activation by innate immune receptor RIG-I. Nature 479: 423–427.
18. KowalinskiE, LunardiT, McCarthyAA, LouberJ, BrunelJ, et al. (2011) Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by viral RNA. Cell 147: 423–435.
19. LuoD, DingSC, VelaA, KohlwayA, LindenbachBD, et al. (2011) Structural insights into RNA recognition by RIG-I. Cell 147: 409–422.
20. BaumA, SachidanandamR, García-SastreA (2010) Preference of RIG-I for short viral RNA molecules in infected cells revealed by next-generation sequencing. Proc Natl Acad Sci USA 107: 16303–16308.
21. HornungV, EllegastJ, KimS, BrzózkaK, JungA, et al. (2006) 5′-Triphosphate RNA is the ligand for RIG-I. Science 314: 994–997.
22. PichlmairA, SchulzO, TanCP, NäslundTI, LiljeströmP, et al. (2006) RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314: 997–1001.
23. SchleeM, RothA, HornungV, HagmannCA, WimmenauerV, et al. (2009) Recognition of 5′ triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. Immunity 31: 25–34.
24. KatoH, TakeuchiO, Mikamo-SatohE, HiraiR, KawaiT, et al. (2008) Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid–inducible gene-I and melanoma differentiation–associated gene 5. J Exp Med 205: 1601–1610.
25. PichlmairA, SchulzO, TanC-P, RehwinkelJ, KatoH, et al. (2009) Activation of MDA5 requires higher-order RNA structures generated during virus infection. J Virol 83: 10761–10769.
26. BerkeIC, ModisY (2012) MDA5 cooperatively forms dimers and ATP-sensitive filaments upon binding double-stranded RNA. EMBO J 31: 1714–1726.
27. BerkeIC, YuX, ModisY, EgelmanEH (2012) MDA5 assembles into a polar helical filament on dsRNA. Proc Natl Acad Sci USA 109: 18437–18441.
28. PeisleyA, LinC, WuB, Orme-JohnsonM, LiuM, et al. (2011) Cooperative assembly and dynamic disassembly of MDA5 filaments for viral dsRNA recognition. Proc Natl Acad Sci USA 108: 21010–21015.
29. AndrejevaJ, ChildsKS, YoungDF, CarlosTS, StockN, et al. (2004) The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-β promoter. Proc Natl Acad Sci USA 101: 17264–17269.
30. ChildsK, StockN, RossC, AndrejevaJ, HiltonL, et al. (2007) mda-5, but not RIG-I, is a common target for paramyxovirus V proteins. Virology 359: 190–200.
31. ParisienJ-P, BammingD, KomuroA, RamachandranA, RodriguezJJ, et al. (2009) A Shared Interface Mediates Paramyxovirus Interference with Antiviral RNA Helicases MDA5 and LGP2. J Virol 83: 7252–7260.
32. MotzC, SchuhmannKM, KirchhoferA, MoldtM, WitteG, et al. (2013) Paramyxovirus V proteins disrupt the fold of the RNA sensor MDA5 to inhibit antiviral signaling. Science 339: 690–693.
33. SaitoT, OwenDM, JiangF, MarcotrigianoJ, GaleMJr (2008) Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature 454: 523–527.
34. SchnellG, LooY-M, MarcotrigianoJ, GaleMJr (2012) Uridine composition of the poly-U/UC tract of HCV RNA defines non-self recognition by RIG-I. PLoS Path 8: e1002839.
35. LuthraP, SunD, SilvermanRH, HeB (2011) Activation of IFN-β expression by a viral mRNA through RNase L and MDA5. Proc Natl Acad Sci USA 108: 2118–2123.
36. FengQ, HatoSV, LangereisMA, ZollJ, Virgen-SlaneR, et al. (2012) MDA5 Detects the double-stranded RNA replicative form in picornavirus-infected cells. Cell reports 2: 1187–1196.
37. HafnerM, LandthalerM, BurgerL, KhorshidM, HausserJ, et al. (2010) Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 141: 129–141.
38. del ValleJR, DevauxP, HodgeG, WegnerNJ, McChesneyMB, et al. (2007) A vectored measles virus induces hepatitis B surface antigen antibodies while protecting macaques against measles virus challenge. J Virol 81: 10597–10605.
39. SchnellMJ, MebatsionT, ConzelmannK-K (1994) Infectious rabies viruses from cloned cDNA. EMBO J 13: 4195.
40. HoskinsJ, SandersF (1957) Propagation of mouse encephalomyocarditis virus in ascites tumour cells maintained in vitro. Br J Exp Pathol 38: 268.
41. OsorioJE, MartinLR, PalmenbergAC (1996) The immunogenic and pathogenic potential of short poly (C) tract Mengo viruses. Virology 223: 344–350.
42. ColonnoRJ, BanerjeeAK (1976) A unique RNA species involved in initiation of vesicular stomatitis virus RNA transcription in vitro. Cell 8: 197–204.
43. LeppertM, RittenhouseL, PerraultJ, SummersDF, KolakofskyD (1979) Plus and minus strand leader RNAs in negative strand virus-infected cells. Cell 18: 735–747.
44. CattaneoR, RebmannG, SchmidA, BaczkoK, Ter MeulenV, et al. (1987) Altered transcription of a defective measles virus genome derived from a diseased human brain. EMBO J 6: 681.
45. PlumetS, DuprexWP, GerlierD (2005) Dynamics of viral RNA synthesis during measles virus infection. J Virol 79: 6900–6908.
46. MottetG, CurranJ, RouxL (1990) Intracellular stability of nonreplicating paramyxovirus nucleocapsids. Virology 176: 1–7.
47. CalainP, CurranJ, KolakofskyD, RouxL (1992) Molecular cloning of natural paramyxovirus copy-back defective interfering RNAs and their expression from DNA. Virology 191: 62–71.
48. CalainP, RouxL (1988) Generation of measles virus defective interfering particles and their presence in a preparation of attenuated live-virus vaccine. J Virol 62: 2859–2866.
49. PfallerCK, RadekeMJ, CattaneoR, SamuelCE (2014) Measles Virus C Protein Impairs Production of Defective Copyback Double-Stranded Viral RNA and Activation of Protein Kinase R. J Virol 88: 456–468.
50. RimaB, DavidsonW, MartinS (1977) The role of defective interfering particles in persistent infection of Vero cells by measles virus. J Gen Virol 35: 89–97.
51. WhistlerT, BelliniWJ, RotaP (1996) Generation of defective interfering particles by two vaccine strains of measles virus. Virology 220: 480–484.
52. WoodHM, BelvedereO, ConwayC, DalyC, ChalkleyR, et al. (2010) Using next-generation sequencing for high resolution multiplex analysis of copy number variation from nanogram quantities of DNA from formalin-fixed paraffin-embedded specimens. Nucleic Acids Res 38: e151–e151.
53. LorenzR, BernhartSH, Zu SiederdissenCH, TaferH, FlammC, et al. (2011) ViennaRNA Package 2.0. Algorithms Mol Biol 6: 26.
54. DeddoucheS, GoubauD, RehwinkelJ, ChakravartyP, BegumS, et al. (2014) Identification of an LGP2-associated MDA5 agonist in picornavirus-infected cells. eLife 3: e01535.
55. BlumbergBM, LeppertM, KolakofskyD (1981) Interaction of VSV leader RNA and nucleocapsid protein may control VSV genome replication. Cell 23: 837–845.
56. Mottet-OsmanG, IseniF, PeletT, WiznerowiczM, GarcinD, et al. (2007) Suppression of the Sendai virus M protein through a novel short interfering RNA approach inhibits viral particle production but does not affect viral RNA synthesis. J Virol 81: 2861–2868.
57. ReuterT, WeissbrichB, Schneider-SchauliesS, Schneider-SchauliesJ (2006) RNA interference with measles virus N, P, and L mRNAs efficiently prevents and with matrix protein mRNA enhances viral transcription. J Virol 80: 5951–5957.
58. VidalS, KolakofskyD (1989) Modified model for the switch from Sendai virus transcription to replication. J Virol 63: 1951–1958.
59. AblasserA, BauernfeindF, HartmannG, LatzE, FitzgeraldKA, et al. (2009) RIG-I-dependent sensing of poly (dA: dT) through the induction of an RNA polymerase III–transcribed RNA intermediate. Nat Immunol 10: 1065–1072.
60. PatelJR, JainA, ChouYy, BaumA, HaT, et al. (2013) ATPase-driven oligomerization of RIG-I on RNA allows optimal activation of type-I interferon. EMBO reports 14: 780–787.
61. GorbalenyaAE, KooninEV, DonchenkoAP, BlinovVM (1989) Two related superfamilies of putative helicases involved in replication, recombination, repair and expression of DNA and RNA genomes. Nucleic Acids Res 17: 4713–4730.
62. RandallRE, GoodbournS (2008) Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 89: 1–47.
63. Gerlier D, Valentin H (2009) Measles virus interaction with host cells and impact on innate immunity. Measles: Springer. pp. 163–191.
64. LangmeadB, TrapnellC, PopM, SalzbergSL (2009) Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10: R25.
65. LiH, HandsakerB, WysokerA, FennellT, RuanJ, et al. (2009) The sequence alignment/map format and SAMtools. Bioinformatics 25: 2078–2079.
66. PlumetS, GerlierD (2005) Optimized SYBR green real-time PCR assay to quantify the absolute copy number of measles virus RNAs using gene specific primers. J Virol Methods 128: 79–87.
67. SparrerKM, PfallerCK, ConzelmannK-K (2012) Measles virus C protein interferes with Beta interferon transcription in the nucleus. J Virol 86: 796–805.